SCHEMBL609898

SCHEMBL609898

O=C(CCc1ccccc1)NC(c1cccs1)c1cc(Cl)c2cccnc2c1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 6/20 1.00
RAB9A P51151 6/20 1.00
MEN1 O00255 5/20 1.00
KMT2A Q03164 5/20 1.00
ALDH1A1 P00352 3/20 1.00
KDM4E B2RXH2 8/20 0.80
TDP1 Q9NUW8 6/20 0.80
NPC1 O15118 6/20 0.80
NPSR1 Q6W5P4 1/20 0.80
LMNA P02545 5/20 0.76
ALOX12 P18054 10/20 0.75
L3MBTL1 Q9Y468 4/20 0.60
HTT P42858 3/20 0.60
SMN1; SMN2 Q16637 3/20 0.60
TP53 P04637 2/20 0.60
PSMD14 O00487 2/20 0.60
MMP2 P08253 2/20 0.60
MAPT P10636 2/20 0.60
USP2 O75604 1/20 0.58
ALOX15 P16050 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL609671 0.89 KDM4E (1.00) HSP90AA1RAB9AMEN1KMT2AALDH1A1
SCHEMBL1815008 0.87 HSP90AA1 (0.77) HSP90AA1RAB9AMEN1KMT2AALDH1A1
SCHEMBL608915 0.86 KDM4E (1.00) HSP90AA1RAB9AMEN1KMT2AALDH1A1
SCHEMBL609894 0.86 ALOX12 (1.00) HSP90AA1RAB9AMEN1KMT2AALDH1A1
SCHEMBL610254 0.86 ADAMTS5 (0.76) HSP90AA1RAB9AMEN1KMT2AALDH1A1
SCHEMBL1818084 0.86 ADAMTS5 (0.77) HSP90AA1RAB9AMEN1KMT2AALDH1A1
SCHEMBL608085 0.85 KDM4E (0.79) HSP90AA1RAB9AMEN1KMT2AALDH1A1
SCHEMBL607476 0.85 HSP90AA1 (0.74) HSP90AA1RAB9AMEN1KMT2AALDH1A1
SCHEMBL610665 0.84 ADAMTS5 (0.74) HSP90AA1RAB9AMEN1KMT2AALDH1A1
SCHEMBL610546 0.84 HSP90AA1 (0.72) HSP90AA1RAB9AMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210198244-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2021-07-01 US claimed
US-20170334890-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2017-11-23 US claimed
US-20150210674-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2015-07-30 US claimed
US-9000009-B2 Small molecule activators of mitochondrial function THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2015-04-07 US claimed
WO-2010068767-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2010-06-17 WO claimed
US-20210198244-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2021-07-01 US disclosed
US-10745390-B2 Small molecule activators of mitochondrial function THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2020-08-18 US disclosed
US-20170334890-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2017-11-23 US disclosed
US-9695157-B2 Small molecule activators of mitochondrial function THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2017-07-04 US disclosed
US-20150210674-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2015-07-30 US disclosed
US-9000009-B2 Small molecule activators of mitochondrial function THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2015-04-07 US disclosed
US-20120041023-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-02-16 US disclosed
WO-2010068767-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2010-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150210674-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION TFAM, TFB2M, GFM1 HSP90AA1 585/4885RAB9A 1259/4885MEN1 4113/4885
US-20170334890-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION TFAM, TFB2M, GFM1 HSP90AA1 585/4885RAB9A 1259/4885MEN1 4113/4885
US-20120041023-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION TFAM, TFB2M, GFM1 HSP90AA1 599/4885RAB9A 1391/4885MEN1 4050/4885
US-10745390-B2 Small molecule activators of mitochondrial function TFAM, TFB2M, GFM1 HSP90AA1 585/4885RAB9A 1259/4885MEN1 4113/4885
US-20210198244-A1 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION TFAM, TFB2M, GFM1 HSP90AA1 585/4885RAB9A 1259/4885MEN1 4113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.